Almost half of individuals with eating disorders also misuse substances, significantly higher than those without eating disorders. Conversely, over a third of those with substance use disorders have an eating disorder. Anorexia nervosa and bulimia nervosa are the main recognized eating disorders. Many individuals with these disorders utilize substances like cocaine to manage weight or appetite. No FDA-approved treatments exist for anorexia or bulimia, and self-medication with cannabis and psychedelics is common. Concurrent disorders increase the risk of untreated cases, necessitating more integrated treatment pathways.
Research shows that up to 50 percent of individuals with eating disorders also engage in alcohol or drug use, highlighting a significant overlap between these conditions.
No FDA-approved treatments exist for anorexia nervosa and bulimia nervosa, prompting individuals to self-medicate with substances like cannabis and psychedelics, which some find helpful.
Emerging clinical trials and pilot data on the use of psilocybin offer hope for new therapeutic approaches in treating individuals with eating disorders and co-occurring substance use disorders.
The high rates of concurrent eating disorders and substance use disorders demonstrate the necessity for integrated treatment options, as many individuals remain undertreated.
Collection
[
|
...
]